A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy

scientific article published on 20 March 2013

A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/CIA.S40087
P932PMC publication ID3610439
P698PubMed publication ID23682212

P50authorLennart MinthonQ66724775
Elisabet LondosQ66724780
Carina WattmoQ92523170
P2093author name stringElisabeth Paulsson
P2860cites workLong-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor TreatmentQ51037244
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.Q51558760
Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.Q51906755
Cognitive impairment, caregiver burden, and the utilization of home health services.Q52016959
Assessment of older people: self-maintaining and instrumental activities of daily livingQ66829682
Predicting the Volume of Health and Social Services: Integrating Cognitive Impairment into the Modified Andersen FrameworkQ67754245
The impact of female caregivers' employment status on patterns of formal and informal eldercareQ74702709
The systems of care for frail elderly persons: the case of SwedenQ78601808
Gender differences in use and availability of home and community-based services for people with dementiaQ81222761
Determinants of costs of care for patients with Alzheimer's diseaseQ22252908
Cholinesterase inhibitors for Alzheimer's diseaseQ22252975
“Mini-mental state”Q25938989
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezilQ33459417
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.Q33979412
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's diseaseQ35465836
Home health care utilization: a review of the research for social workQ35903745
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 yearsQ36107758
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam studyQ36903154
Community care for demented and non-demented elderly people: a comparison study of financial burden, service use, and unmet needs in family supportersQ36903872
The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.Q38743854
Dementia and help with household tasks: a comparison of cases and non-casesQ39528752
The amount of informal and formal care among non-demented and demented elderly persons-results from a Swedish population-based study.Q40395103
Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII.Q40896300
Donepezil is associated with delayed nursing home placement in patients with Alzheimer's diseaseQ42602615
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapyQ42681493
Home nursing and home help for dementia patients: Predictors for utilization and expected quality from a family caregiver's point of view.Q43593187
The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trialQ44766915
Incremental patterns in the amount of informal and formal care among non-demented and demented elderly persons: results from a 3-year follow-up population-based studyQ44962837
Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysisQ46375583
Predictors of cognitive and functional progression in patients with probable Alzheimer's diseaseQ48884069
The role of cognitive status in the use of inhome services: implications for nursing assessment.Q50155127
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
P304page(s)329-339
P577publication date2013-03-20
P1433published inClinical Interventions in AgingQ5133768
P1476titleA longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy
P478volume8

Reverse relations

cites work (P2860)
Q92523174Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
Q36118948Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death
Q55456183Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.
Q35144642Donepezil and life expectancy in Alzheimer's disease: a retrospective analysis in the Tajiri Project
Q40607418Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease
Q35834150Lifetime expectancy and quality-adjusted life-year in Alzheimer's disease with and without cerebrovascular disease: effects of nursing home replacement and donepezil administration--a retrospective analysis in the Tajiri Project
Q88631521Longitudinal changes in quality of life among elderly people with and without dementia
Q53356856Measures to prevent Alzheimer's patients from discontinuing the use of cholinesterase inhibitors.
Q35218713Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
Q37690649Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies
Q36264977Real-world evaluation of compliance and preference in Alzheimer's disease treatment
Q34233759Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
Q47862426Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study
Q34548336Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services
Q48299438Telephone-based Minnesota Cognitive Acuity Screen predicts time to institutionalization and homecare
Q36072043The Agreement between the MMSE and IQCODE Tests in a Community-Based Sample of Subjects Aged 70 Years or Older Receiving In-Home Nursing: An Explorative Study
Q36572028The impact of dementia on the use of general practitioners among the elderly in Norway

Search more.